AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model.

MLA

Rabaça, Aline N., et al. “AC-1001 H3 CDR Peptide Induces Apoptosis and Signs of Autophagy in Vitro and Exhibits Antimetastatic Activity in a Syngeneic Melanoma Model.” FEBS Open Bio, vol. 6, no. 9, July 2016, pp. 885–901. EBSCOhost, https://doi.org/10.1002/2211-5463.12080.

APA

Rabaça, A. N., Arruda, D. C., Figueiredo, C. R., Massaoka, M. H., Farias, C. F., Tada, D. B., Maia, V. C., Silva Junior, P. I., Girola, N., Real, F., Mortara, R. A., Polonelli, L., & Travassos, L. R. (2016). AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model. FEBS Open Bio, 6(9), 885–901. https://doi.org/10.1002/2211-5463.12080

Chicago

Rabaça, Aline N, Denise C Arruda, Carlos R Figueiredo, Mariana H Massaoka, Camyla F Farias, Dayane B Tada, Vera C Maia, et al. 2016. “AC-1001 H3 CDR Peptide Induces Apoptosis and Signs of Autophagy in Vitro and Exhibits Antimetastatic Activity in a Syngeneic Melanoma Model.” FEBS Open Bio 6 (9): 885–901. doi:10.1002/2211-5463.12080.